Loading
Allurion Technologies, Inc. Stock: price and insider trades · United States
US·Mcap US$314.2k
No insider purchase over the last 90 days. The latest was filed 21 May 2025.
Allurion Technologies, Inc.: what insiders have been doing
Every trade that managers of Allurion Technologies, Inc. disclose to SEC (Form 4) is tracked on this page. Between 18 October 2025 and 18 October 2026, 2 insiders published 7 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Compared with its exchange (5,808 companies, median 19 filings), a count of 7 filings is below the norm. Looking back to 2023, when coverage begins, insiders filed 2 purchases and no sales.
No insider has bought Allurion Technologies, Inc. shares on the open market in the past twelve months. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4.
For comparison within the same market, see the insider buying recorded at GameStop Corp. and Heico Corp. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
20
Thresholds
n/a
Buy Volume
€46,608
2 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleShantanu Gaur2 buys
Since the insiders bought
- -71.9%Entry US$2.95 · Close at T+365 US$0.83
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$0.52
Analyst consensus
2 analystsUS$45.00Target US$82.50(+15857%)US$120.00
Income statement
RevenueUS$15.2M
Gross profitUS$9.6M63% margin
EBITDA-US$27.7M-182% margin
Net income-US$28.8M-264.7% margin
Valuation
Beta-0.13
Balance sheet & cash
Market capUS$314.2k
Total debtUS$29M
Free Cash Flow-US$28.9M
Profitability & ownership
ROA-66.8%
% insiders5.2%
% institutions7.9%
Last declaration on 23 July 2026
Declarations20 total
209,254 sharesCommon Stock, $0.0001 par value per shareSEC:0001231919-26-000786:0
161,807 sharesCommon Stock, $0.0001 par value per shareSEC:0001231919-26-000786:1
19,934 sharesCommon Stock, $0.0001 par value per shareSEC:0001231919-26-000786:2
1,771 sharesCommon Stock, $0.0001 par value per shareSEC:0001231919-26-000786:3
604 shares0Common StockSEC:0001193125-25-310088:0
991,544 shares@ US$1.6722.9% of flowCommon Stock, $0.0001 par value per shareSEC:0001231919-25-000468:0
822,722 shares@ US$3.3538.4% of flowCommon Stock, $0.0001 par value per shareSEC:0001231919-25-000449:0
8,000 shares@ US$3.060546.8% of flowCommon StockSEC:0000950170-25-075780:0
Canonical exit: 17 Aug 2025 (T+90)
822,722 shares@ US$3.3538.7% of flowCommon Stock, $0.0001 par value per shareSEC:0001062993-25-007660:0
8,000 shares@ US$3.3553.2% of flowCommon StockSEC:0000950170-25-048527:0
Canonical exit: 26 Jun 2025 (T+90)
326,086 shares0Common StockSEC:0000950170-24-125724:0
306,749 shares0Common StockSEC:0000950170-24-125745:0
75,000 shares0Common StockSEC:0000950170-24-034881:0
97,799 shares@ US$1.13100.0% of flowCommon StockSEC:0000950170-23-070517:0
45,235 shares0Common StockSEC:0000950170-23-055244:0
45,235 shares0Common StockSEC:0000950170-23-055241:0
45,235 shares0Common StockSEC:0000950170-23-055251:0
45,235 shares0Common StockSEC:0000950170-23-055247:0
45,235 shares0Common StockSEC:0000950170-23-055245:0
20 of 20 declarations
About Allurion Technologies, Inc.
Allurion Technologies, Inc. is a company focused on developing innovative solutions for weight management. It is listed on the NASDAQ under the ticker ALUR.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
